Caitlin John’s Zomedica Corp. ZOM Stock Holding History

Caitlin John’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-58,500	Closed	-$7.02K	–	860
2024 Q4	$7.02K	Hold	58,500	–	–	﹤0.01%	528
2024 Q3	$8.65K	Hold	58,500	–	–	0.01%	503
2024 Q2	$8.55K	Sell	58,500 -2,000	-3%	-$300	0.01%	484
2024 Q1	$8.83K	Hold	60,500	–	–	0.01%	477
2023 Q4	$12.1K	Buy	+60,500	New	+$10.6K	0.01%	410

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

PRTG

Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return

JWM

Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Caitlin John's ZOM Position: Q1 2025 in Review

Caitlin John sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 58,500 shares — an estimated $7.02K sold.

Caitlin John first reported a position in ZOM in Q4 2023 and held it in 5 quarters. The position peaked at $12.1K in Q4 2023. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

Caitlin John reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
Caitlin John sold 58,500 Zomedica Corp. shares in Q1 2025, an estimated $7.02K.
Caitlin John first reported a position in Zomedica Corp. in Q4 2023 and held it in 5 quarters.
Caitlin John's Zomedica Corp. position peaked at $12.1K in Q4 2023.
23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Caitlin John's 13F filing for Q1 2025, filed 14 May 2025.